Gland Pharma Limited (GLAND) Share Price & AI Investment Analysis

Gland Pharma Limited engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally. It engages in research and development of active pharmaceutical ingredient products, including synthesis of complex drug molecules, such as low molecular weight heparins, corticosteroids, peptides, and cytotoxic molecules. The company also offers its products for various therapeutic categories, such as anti- diabetic, anti-malarial, anti-infectives, anti-neoplastic, and neurological and central nervous system; blood related,. Track Gland Pharma Limited's live NSE:GLAND share price ₹2,902.60 (-0.18%), market cap ₹₹479B, P/E 42.7. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for GLAND — real-time NSE India stock intelligence.